Your browser doesn't support javascript.
loading
CXCL13 is a plasma biomarker of germinal center activity.
Havenar-Daughton, Colin; Lindqvist, Madelene; Heit, Antje; Wu, Jennifer E; Reiss, Samantha M; Kendric, Kayla; Bélanger, Simon; Kasturi, Sudhir Pai; Landais, Elise; Akondy, Rama S; McGuire, Helen M; Bothwell, Marcella; Vagefi, Parsia A; Scully, Eileen; Tomaras, Georgia D; Davis, Mark M; Poignard, Pascal; Ahmed, Rafi; Walker, Bruce D; Pulendran, Bali; McElrath, M Juliana; Kaufmann, Daniel E; Crotty, Shane.
Afiliação
  • Havenar-Daughton C; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037;
  • Lindqvist M; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA 02114;
  • Heit A; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
  • Wu JE; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
  • Reiss SM; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
  • Kendric K; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
  • Bélanger S; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
  • Kasturi SP; Yerkes National Primate Research Center, Emory University, Atlanta, GA 30322; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
  • Landais E; Neutralizing Antibody Center, International AIDS Vaccine Initiative, La Jolla, CA 92037;
  • Akondy RS; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
  • McGuire HM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94304;
  • Bothwell M; Department of Surgery, University of California, San Diego, CA 92123; Pediatric Otolaryngology, Rady Children's Hospital-San Diego, San Diego, CA 92123;
  • Vagefi PA; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114;
  • Scully E; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA 02114;
  • Tomaras GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710;
  • Davis MM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94304; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94304;
  • Poignard P; Neutralizing Antibody Center, International AIDS Vaccine Initiative, La Jolla, CA 92037; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037;
  • Ahmed R; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
  • Walker BD; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA 02114; Howard Hughes Medical Institute, Chevy Chase, MD 20815;
  • Pulendran B; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Yerkes National Primate Research Center, Emory University, Atlanta, GA 30322; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322;
  • McElrath MJ; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
  • Kaufmann DE; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA 02114; Department of Medicine, Université de Montréal, Montreal, QC H2X 0A9, Canada; Centre
  • Crotty S; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, La Jolla, CA 92037; shane@lji.org.
Proc Natl Acad Sci U S A ; 113(10): 2702-7, 2016 Mar 08.
Article em En | MEDLINE | ID: mdl-26908875
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Centro Germinativo / Quimiocina CXCL13 Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Centro Germinativo / Quimiocina CXCL13 Idioma: En Ano de publicação: 2016 Tipo de documento: Article